Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152501 | SCV000201665 | likely benign | not specified | 2013-08-13 | criteria provided, single submitter | clinical testing | Thr1791Thr in exon 28 of TTN: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. Thr1791Thr in exon 28 of TTN: (allele freque ncy = n/a) |
Eurofins Ntd Llc |
RCV000724889 | SCV000332165 | uncertain significance | not provided | 2015-06-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000548358 | SCV000643344 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000152501 | SCV001433118 | benign | not specified | 2020-02-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336307 | SCV002645348 | likely benign | Cardiovascular phenotype | 2019-06-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |